重新审视肠胰岛轴。肠促胰岛素的新作用。 - Suppr

Suppr

超能文献

The enteroinsular axis revisited. A novel role for an incretin.

作者信息

Ensinck J W, D'Alessio D A

出版信息

N Engl J Med. 1992 May 14;326(20):1352-3. doi: 10.1056/NEJM199205143262009.

DOI:10.1056/NEJM199205143262009

PMID:1565148

Abstract

摘要

相似文献

The enteroinsular axis revisited. A novel role for an incretin.

N Engl J Med. 1992 May 14;326(20):1352-3. doi: 10.1056/NEJM199205143262009.

Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.

Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):461-8. doi: 10.1097/01.mco.0000078991.96795.84.

On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.

Dan Med Bull. 2004 Nov;51(4):364-70.

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.

N Engl J Med. 1992 May 14;326(20):1316-22. doi: 10.1056/NEJM199205143262003.

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13. doi: 10.1210/jc.2002-021873.

Possible role of the adrenergic mechanism in gastric inhibitory polypeptide- and glucagon-like peptide-1 (7-36) amide-induced insulin release in the rat.

Metabolism. 1993 Feb;42(2):209-13. doi: 10.1016/0026-0495(93)90037-o.

[Gluco-incretin hormones in insulin secretion and diabetes].

Med Sci (Paris). 2003 Aug-Sep;19(8-9):860-3. doi: 10.1051/medsci/20031989860.

Glucagon-like peptide-1 (7-37) augments insulin release in elderly patients with diabetes.

Diabetes Care. 2001 May;24(5):964-5. doi: 10.2337/diacare.24.5.964.

Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.

Diabetologia. 2003 Feb;46(2):222-30. doi: 10.1007/s00125-002-1028-x. Epub 2003 Feb 12.

New developments in the incretin concept.

Diabetologia. 1985 Aug;28(8):565-73. doi: 10.1007/BF00281990.

引用本文的文献

DPP-4 Inhibition and the Path to Clinical Proof.

Front Endocrinol (Lausanne). 2019 Jun 19;10:376. doi: 10.3389/fendo.2019.00376. eCollection 2019.

Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development.

J Diabetes Investig. 2019 Mar;10(2):196-201. doi: 10.1111/jdi.12911. Epub 2018 Sep 17.

Attenuated GLP-1 secretion in obesity: cause or consequence?

Gut. 1996 Jun;38(6):916-9. doi: 10.1136/gut.38.6.916.

Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.

Acta Diabetol. 1996 Mar;33(1):19-24. doi: 10.1007/BF00571935.

In vivo expression of mutant preproendothelins: hierarchy of processing events but no strict requirement of Trp-Val at the processing site.

Proc Natl Acad Sci U S A. 1993 May 1;90(9):3923-7. doi: 10.1073/pnas.90.9.3923.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验